Understanding chronic myelomonocytic leukemia to improve nursing care.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: this hematologic malignancy
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This article discusses the pathophysiology, diagnosis, complications, and management of CMML, as well as nursing considerations when caring for patients with this hematologic malignancy. It aims to define unique characteristics of CMML to aid nurses in providing effective care to these patients.
Chronic myelomonocytic leukemia (CMML) is a rare, aggressive type of leukemia that can exhibit myeloproliferative and myelodysplastic features and has a propensity to transform into acute myeloid leuk
APA
Klepitsch E, Ignatiev E, et al. (2026). Understanding chronic myelomonocytic leukemia to improve nursing care.. Nursing, 56(2), 24-31. https://doi.org/10.1097/NSG.0000000000000320
MLA
Klepitsch E, et al.. "Understanding chronic myelomonocytic leukemia to improve nursing care.." Nursing, vol. 56, no. 2, 2026, pp. 24-31.
PMID
41582402 ↗
Abstract 한글 요약
Chronic myelomonocytic leukemia (CMML) is a rare, aggressive type of leukemia that can exhibit myeloproliferative and myelodysplastic features and has a propensity to transform into acute myeloid leukemia (AML). CMML is characterized by specific cytogenetic abnormalities and identified laboratory findings that support the diagnosis. Clinical manifestations of the disorder depend on disease subtype. Current treatments are supportive with a goal of increasing time to transformation into AML and decreasing end-organ damage. The only known cure for CMML is allogeneic stem cell transplant. This article discusses the pathophysiology, diagnosis, complications, and management of CMML, as well as nursing considerations when caring for patients with this hematologic malignancy. It aims to define unique characteristics of CMML to aid nurses in providing effective care to these patients.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.